Cargando…
Fibromyalgia is associated to receiving chronic medications beyond appropriateness: a cross-sectional study
The objectives of this study are to describe appropriateness and drug treatment of comorbidities in fibromyalgia (FM). Cross-sectional study of a group of patients. Number of drugs, indication, duration and appropriateness of prescriptions were evaluated. Patients were classified as: group 1, (FM/FM...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102937/ https://www.ncbi.nlm.nih.gov/pubmed/27664140 http://dx.doi.org/10.1007/s00296-016-3568-2 |
_version_ | 1782466505879846912 |
---|---|
author | Rivera, Javier Vallejo, Miguel A. |
author_facet | Rivera, Javier Vallejo, Miguel A. |
author_sort | Rivera, Javier |
collection | PubMed |
description | The objectives of this study are to describe appropriateness and drug treatment of comorbidities in fibromyalgia (FM). Cross-sectional study of a group of patients. Number of drugs, indication, duration and appropriateness of prescriptions were evaluated. Patients were classified as: group 1, (FM/FM) previous FM diagnosis and fulfilling criteria; group 2, (noFM/noFM) other diagnosis and not fulfilling criteria; and group 3, (noFM/FM) other diagnosis but fulfilling criteria. Drugs were classified into drugs for nervous system, analgesics/NSAID and drugs for other comorbidities. Appropriateness was evaluated following clinical therapeutic guidelines. A total of 159 patients were included in the study and classified into group 1, with 59 patients; group 2, with 67 patients; and group 3, with 33 patients. Group 1 received a greater number of different drugs and for a longer period of time, there were less severe comorbidities and more unjustified treatments. No difference was found between the other two groups. Major opioids were only consumed in group 1. Also, in group 1, 45.8 % of patients were attended in psychiatry versus 15.6 % in group 3 and 3 % in group 2. The number of somatic symptoms correlated significantly with the number of drugs. Nervous system treatments were of shorter duration than other drug treatments. There was no difference in severe comorbidities. Comorbidities in FM are similar to those of other patients, but they receive more drugs and for a longer period of time. Drugs for nervous system comorbidities are introduced later, when other somatic symptoms are already treated. In patients with FM the treatments for mild comorbidities are not well justified. |
format | Online Article Text |
id | pubmed-5102937 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-51029372016-11-21 Fibromyalgia is associated to receiving chronic medications beyond appropriateness: a cross-sectional study Rivera, Javier Vallejo, Miguel A. Rheumatol Int Food for Thought The objectives of this study are to describe appropriateness and drug treatment of comorbidities in fibromyalgia (FM). Cross-sectional study of a group of patients. Number of drugs, indication, duration and appropriateness of prescriptions were evaluated. Patients were classified as: group 1, (FM/FM) previous FM diagnosis and fulfilling criteria; group 2, (noFM/noFM) other diagnosis and not fulfilling criteria; and group 3, (noFM/FM) other diagnosis but fulfilling criteria. Drugs were classified into drugs for nervous system, analgesics/NSAID and drugs for other comorbidities. Appropriateness was evaluated following clinical therapeutic guidelines. A total of 159 patients were included in the study and classified into group 1, with 59 patients; group 2, with 67 patients; and group 3, with 33 patients. Group 1 received a greater number of different drugs and for a longer period of time, there were less severe comorbidities and more unjustified treatments. No difference was found between the other two groups. Major opioids were only consumed in group 1. Also, in group 1, 45.8 % of patients were attended in psychiatry versus 15.6 % in group 3 and 3 % in group 2. The number of somatic symptoms correlated significantly with the number of drugs. Nervous system treatments were of shorter duration than other drug treatments. There was no difference in severe comorbidities. Comorbidities in FM are similar to those of other patients, but they receive more drugs and for a longer period of time. Drugs for nervous system comorbidities are introduced later, when other somatic symptoms are already treated. In patients with FM the treatments for mild comorbidities are not well justified. Springer Berlin Heidelberg 2016-09-23 2016 /pmc/articles/PMC5102937/ /pubmed/27664140 http://dx.doi.org/10.1007/s00296-016-3568-2 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Food for Thought Rivera, Javier Vallejo, Miguel A. Fibromyalgia is associated to receiving chronic medications beyond appropriateness: a cross-sectional study |
title | Fibromyalgia is associated to receiving chronic medications beyond appropriateness: a cross-sectional study |
title_full | Fibromyalgia is associated to receiving chronic medications beyond appropriateness: a cross-sectional study |
title_fullStr | Fibromyalgia is associated to receiving chronic medications beyond appropriateness: a cross-sectional study |
title_full_unstemmed | Fibromyalgia is associated to receiving chronic medications beyond appropriateness: a cross-sectional study |
title_short | Fibromyalgia is associated to receiving chronic medications beyond appropriateness: a cross-sectional study |
title_sort | fibromyalgia is associated to receiving chronic medications beyond appropriateness: a cross-sectional study |
topic | Food for Thought |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102937/ https://www.ncbi.nlm.nih.gov/pubmed/27664140 http://dx.doi.org/10.1007/s00296-016-3568-2 |
work_keys_str_mv | AT riverajavier fibromyalgiaisassociatedtoreceivingchronicmedicationsbeyondappropriatenessacrosssectionalstudy AT vallejomiguela fibromyalgiaisassociatedtoreceivingchronicmedicationsbeyondappropriatenessacrosssectionalstudy |